A Robust and Novel Approach for Brain Tumor Classification Using Convolutional Neural Network. (21st December 2021)

• Record Type: Journal Article
• Authors: Tazin, Tahia; Sarker, Sraboni; Gupta, Punit; Ayaz, Fozayel Ibn; Islam, Sumaia; Monirujjaman Khan, Mohammad; Bourouis, Sami; Idris, Sahar Ahmed; Alshazly, Hammam
• Other Names: Gupta Suneet Kumar Academic Editor.
• Is Part Of: Computational intelligence and neuroscience. Volume 2021(2021)
• Publication Date: 2021-12-21
• Subjects: Neurosciences -- Data processing -- Periodicals; Computational intelligence -- Periodicals; Computational neuroscience -- Periodicals; 612.80285
• DOI: 10.1155/2021/2392395
• Languages: English
• ISSNs: 1687-5265

Abstract

Abstract : Brain tumors are the most common and aggressive illness, with a relatively short life expectancy in their most severe form. Thus, treatment planning is an important step in improving patients' quality of life. In general, image methods such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound images are used to assess tumors in the brain, lung, liver, breast, prostate, and so on. X-ray images, in particular, are utilized in this study to diagnose brain tumors. This paper describes the investigation of the convolutional neural network (CNN) to identify brain tumors from X-ray images. It expedites and increases the reliability of the treatment. Because there has been a significant amount of study in this field, the presented model focuses on boosting accuracy while using a transfer learning strategy. Python and Google Colab were utilized to perform this investigation. Deep feature extraction was accomplished with the help of pretrained deep CNN models, VGG19, InceptionV3, and MobileNetV2. The classification accuracy is used to assess the performance of this paper. MobileNetV2 had the accuracy of 92%, InceptionV3 had the accuracy of 91%, and VGG19 had the accuracy of 88%. MobileNetV2 has offered the highest level of accuracy among these networks. These precisions aid in the early identification of tumors before they produce physical adverse effects such as paralysis and other impairments.